A new medicine for high uric acid in kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new medicine (ABP-671) to see if it can safely lower high uric acid levels in people who also have chronic kidney disease. If you join, you might get the new drug and help researchers find a better way to manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a doctor's diagnosis of chronic kidney disease (CKD).
- Your blood uric acid level is higher than 7.0 mg/dL (420 μmol/L).
- Your body mass index (BMI) is between 18 and 40.
- You have not had a kidney transplant.
- You do not have very high protein in your urine (3.5 grams or more per day) or severe liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, IG3018, to lower high uric acid levels in people with or without chronic kidney disease. It aims to find the right dose and see if it's safe.
This trial tests an experimental tablet (SHR4640) added to the standard gout medicine febuxostat (40 mg daily) for people whose uric acid remains too high despite febuxostat alone. The goal is to see if the combination lowers uric acid more effectively and safely.
This trial tests an investigational tablet called BR2251 to see if it can lower uric acid levels in people with gout and hyperuricemia (too much uric acid in the blood). If you qualify, you may get a new treatment that could help prevent painful gout attacks.
This study tests whether a genetic test can help doctors choose the safest and most effective gout medication. It aims to prevent severe allergic reactions by personalizing treatment based on your genes.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
This study tests a new medicine, NNC4004-0002, for people who have high uric acid levels but no gout symptoms. The goal is to see if it is safe and how well it works in healthy adults aged 35 to 75.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.